Immune function after COVID-19 infection
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Confirmed history of SARS-CoV-2 infection from December 7 to December 31, 2022. (2) Age 18 to 65 years old; (3) Voluntarily sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Those with severe diseases such as heart, liver, kidney, immune system, and hematopoietic system. (2) Individuals with a history of severe emotional disorders or mental illness or a family history of mental illness; (3) Pregnant or lactating women. (4) Due to allergies and other reasons, patients cannot be treated with traditional Chinese medicine prescriptions. (5) Patients with acute COVID-19 infection (re infected with COVID-19 within 2 weeks). (6) After COVID-19 infection, severe fatigue, cough, chest tightness, palpitations, abdominal pain, nausea, dizziness and other COVID-19 complications or sequelae occur, and drug treatment intervention is required. (7) Participated in other clinical trials within one month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection of Treg and Th1, Th2 and Th17;Analysis of TBNK lymphocyte subpopulations; | — |
Secondary
| Measure | Time frame |
|---|---|
| IgG;IgM antibody to novel coronavirus;IgG antibody to novel coronavirus;IgM;IgA;Upper respiratory tract flora; | — |
Countries
China
Contacts
Beijing Hospital of Traditional Chinese Medicine